![French Tech 120 - Promotion 2024](/medias/menu/FRENCH-TECH-FT120-550.png)
French Tech 120 - Promotion 2024
Lancé en 2019 par la Mission French Tech, le French Tech Next40/120 est un programme d’accompagnement de l’État dédié aux 120 start-up françaises les plus performantes, en capacité de devenir leaders de rang international. Elles bénéficient pendant un an d’un accompagnement en lien avec leurs enjeux de développement en France et à l’international.
French Tech 120
2024
![AQEMIA AQEMIA](https://beta.motherbase.ai/media/logo/92133_qo4F8lK.jpeg)
AQEMIA
Scale Drug Discovery with Quantum-inspired Physics and AI Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of experimental data, our pipeline scales the drug discovery process at an unprecedented pace, generating an … [voir plus]
![CorWave CorWave](https://beta.motherbase.ai/media/logo/51714.jpeg)
CorWave
CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic … [voir plus]
![DNA Script DNA Script](https://beta.motherbase.ai/media/logo/74211.jpeg)
DNA Script
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s … [voir plus]
![ImCheck Therapeutics ImCheck Therapeutics](https://beta.motherbase.ai/media/logo/86444.jpeg)
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, … [voir plus]
![TISSIUM TISSIUM](https://beta.motherbase.ai/media/logo/91564.jpeg)
TISSIUM
Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, … [voir plus]
![TreeFrog Therapeutics TreeFrog Therapeutics](https://beta.motherbase.ai/media/logo/52032.jpeg)
TreeFrog Therapeutics
Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant … [voir plus]